Cronos Group Inc (CRON) Total Business Assets

Corporate emblem and logo of Cronos (CRON)

Cronos Group Inc. (CRON) is building global cannabinoid supply chains, which confirms the market trend for total assets at 1178.11 as visualized in monetary terms. However, rising electricity costs for greenhouses and geopolitical export challenges are weighing on profits. Meanwhile, its status as a corporate partner to a tobacco behemoth guarantees the brand high financial stability and investor confidence.

CRON: thecronosgroup.com Aggregate Company Assets 07/04/2022 - 10/28/2026

Analytical breakdowns for Cronos (CRON)

- price and consensus price forecast:
Share Price thecronosgroup.com|CRON - Price Target Chart
- market capitalization data:
Market Capitalization Cronos Corp|CRON - Enterprise Value
- book capitalization data:
Book Value per Share Cronos Group|CRON - Company Book Value|Market Value to Book Value thecronosgroup.com|CRON - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Cronos Group Inc.|CRON - Long-Term Debt to Equity|Current Liabilities to Capital Cronos Corp|CRON - Company Total Debt|Debt to Net Assets Ratio Cronos Corp|CRON - Company Long-Term Debts|Current Liabilities Cronos Group
Analysis of all company metrics:Cronos Group Inc.
Finished products of Cronos Group

When constructing a long-term portfolio, screening total resources allows for an assessment of business scale and resilience to market shocks. This metric, calculated inversely via return on assets (ROA), reflects the total asset value of Cronos Group Inc., which, given local cannabis legislation and low geopolitical risks, determines the real expansion potential, as clearly evidenced by the trajectory of total balance sheet assets.

Competitors of Cronos Group Inc.

INDV (indivior.com) - Total Business Assets|Aggregate Company Assets Collegium Pharmaceutical, Inc. (COLL)|Total Business Assets Canopy Growth Corp|Company Total Assets HITI|Company Total Assets ACB (auroramj.com)|Aggregate Company Assets Achieve Life Sciences|Aggregate Asset Value skyebioscience.com SKYE|ANEB: Company Total Assets|INCR: Cumulative Company Assets|Aggregate Company Assets NTRB|Company Assets Nasus Pharma|IGC - Cumulative Company Assets|Aggregate Asset Value MIRA Pharma|FLGC - Company Total Assets|Total Asset Value of Company imcannabis.com (IMCC)|Company Total Assets ADIL (Adial Pharmaceuticals, Inc.)|Artelo Biosciences Inc. - Company Total Assets|Aggregate Company Assets Ensysce (ENSC)|TTNP: Aggregate Asset Value|GNLN (Greenlane) - Aggregate Company Assets|InMed Pharmaceuticals Inc (INM) - Cumulative Company Assets|Company Total Assets AKAN|Cumulative Company Assets ENVB|Bright Green (BGXX) - Aggregate Company Assets|Aggregate Asset Value HPCO (Hempacco Co Inc.)